FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gilbert Lavielle

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

CHO Cells

Concepts & Ideas

Drug Dose Response Relationship

Co-author Network

Publications

TOP 3
Anne Dekeyne; Benjamin Di Cara; Gunnar Flik; Kevin C F Fone; Alain Gobert; Gilbert Lavielle; Florence Loiseau; Mauricette Brocco; Raymond Cespuglio; Johnny S W Chan; Thomas I Cremers; Berend Olivier; Mariusz Papp; Jean-Michel Rivet; Florence Serres; Trevor Sharp; David J G Watson; Mark J Millan
S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological characterization.
Mark J Millan; O Muller; Adrian Newman-Tancredi; Clotilde Mannoury La Cour; Philippe Marin; Valérie Audinot; Joël Bockaert; Jean A Boutin; Benjamin Chanrion; Didier Cussac; Anne Dekeyne; Benjamin Di Cara; Delphine S Dupuis; Ralf JOckers; Maud Kamal; Gilbert Lavielle
S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
Christine Vayssettes-Courchay; Christophe Ragonnet; Gwenolé Camenen; Michel Félétou; Alex Cordi; Gilbert Lavielle; Tony J Verbeuren
Role of thromboxane TP and angiotensin AT1 receptors in lipopolysaccharide-induced arterial dysfunction in the rabbit: an in vivo study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gilbert Lavielle (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Anne Dekeyne; Benjamin Di Cara; Gunnar Flik; Kevin C F Fone; Alain Gobert; Gilbert Lavielle; Florence Loiseau; Mauricette Brocco; Raymond Cespuglio; Johnny S W Chan; Thomas I Cremers; Berend Olivier; Mariusz Papp; Jean-Michel Rivet; Florence Serres; Trevor Sharp; David J G Watson; Mark J Millan
S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological characterization.
The Journal of pharmacology and experimental therapeutics 2012;340(3):765-80.
2012: Mark J Millan; O Muller; Adrian Newman-Tancredi; Clotilde Mannoury La Cour; Philippe Marin; Valérie Audinot; Joël Bockaert; Jean A Boutin; Benjamin Chanrion; Didier Cussac; Anne Dekeyne; Benjamin Di Cara; Delphine S Dupuis; Ralf JOckers; Maud Kamal; Gilbert Lavielle
S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
The Journal of pharmacology and experimental therapeutics 2012;340(3):750-64.
2010: Christine Vayssettes-Courchay; Christophe Ragonnet; Gwenolé Camenen; Michel Félétou; Alex Cordi; Gilbert Lavielle; Tony J Verbeuren
Role of thromboxane TP and angiotensin AT1 receptors in lipopolysaccharide-induced arterial dysfunction in the rabbit: an in vivo study.
European journal of pharmacology 2010;634(1-3):113-20.
2008: Anne Dekeyne; Clotilde Mannoury La Cour; Alain Gobert; Mauricette Brocco; Françoise Lejeune; Florence Serres; Trevor Sharp; Annie Daszuta; Amélie Soumier; Mariusz Papp; Jean-Michel Rivet; Gunnar Flik; Thomas I Cremers; Olivier Muller; Gilbert Lavielle; Mark J Millan
S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models.
Psychopharmacology 2008;199(4):549-68.
2008: Mark J Millan; Clotilde Mannoury La Cour; Francesca Novi; Roberto Maggio; Valérie Audinot; Adrian Newman-Tancredi; Didier Cussac; Valérie Pasteau; Jean-A Boutin; T Dubuffet; Gilbert Lavielle
S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors.
The Journal of pharmacology and experimental therapeutics 2008;324(2):587-99.
2007: Kazutaka Takagi; Thomas S Dexheimer; Christophe Redon; Olivier Sordet; Keli Agama; Gilbert Lavielle; Alain Pierré; Susan E Bates; Yves Pommier
Novel E-ring camptothecin keto analogues (S38809 and S39625) are stable, potent, and selective topoisomerase I inhibitors without being substrates of drug efflux transporters.
Molecular cancer therapeutics 2007;6(12 Pt 1):3229-38.
2007: Amélie Lansiaux; Stéphane Léonce; Laurence Kraus-Berthier; Christine Bal-Mahieu; Romain Mazinghien; Sébastien Didier; Marie-Hélène David-Cordonnier; Patrick Hautefaye; Gilbert Lavielle; Christian Bailly; John A Hickman; Alain Pierré
Novel stable camptothecin derivatives replacing the E-ring lactone by a ketone function are potent inhibitors of topoisomerase I and promising antitumor drugs.
Molecular pharmacology 2007;72(2):311-9.
2006: Shanqin Xu; Bingbing Jiang; Karlene A Maitland; Hossein Bayat; Jiali Gu; Jerry L Nadler; stefano corda; Gilbert Lavielle; Tony J Verbeuren; Adriana Zuccollo; Richard A Cohen
The thromboxane receptor antagonist S18886 attenuates renal oxidant stress and proteinuria in diabetic apolipoprotein E-deficient mice.
Diabetes 2006;55(1):110-9.
2005: Adriana Zuccollo; Chaomei Shi; Roberto Mastroianni; Karlene A Maitland-Toolan; Robert M Weisbrod; Mengwei Zang; Shanqin Xu; Bingbing Jiang; Jennifer M Oliver-Krasinski; Antonio Cayatte; stefano corda; Gilbert Lavielle; Tony J Verbeuren; Richard A Cohen
The thromboxane A2 receptor antagonist S18886 prevents enhanced atherogenesis caused by diabetes mellitus.
Circulation 2005;112(19):3001-8.
2003: Patrick Hautefaye; Bernard Cimetière; Alain Pierré; Stéphane Léonce; John Hickman; William Laine; Christian Bailly; Gilbert Lavielle
Synthesis and pharmacological evaluation of novel non-lactone analogues of camptothecin.
Bioorganic & medicinal chemistry letters 2003;13(16):2731-5.
2001: Graeme Milligan; Elaine Kellett; Catherine Dacquet; V Dubreuil; E Jacoby; Mark J Millan; Gilbert Lavielle; Michael Spedding
S 14506: novel receptor coupling at 5-HT(1A) receptors.
Neuropharmacology 2001;40(3):334-44.
2000: Antonio Cayatte; Y Du; Jennifer M Oliver-Krasinski; Gilbert Lavielle; Tony J Verbeuren; Richard A Cohen
The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice: evidence that eicosanoids other than thromboxane contribute to atherosclerosis.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(7):1724-8.
2000: Mark J Millan; Anne Dekeyne; Jean-Michel Rivet; T Dubuffet; Gilbert Lavielle; Mauricette Brocco
S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626.
The Journal of pharmacology and experimental therapeutics 2000;293(3):1063-73.
2000: Mark J Millan; Alain Gobert; Adrian Newman-Tancredi; Françoise Lejeune; Didier Cussac; Jean-Michel Rivet; Valérie Audinot; T Dubuffet; Gilbert Lavielle
S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626.
The Journal of pharmacology and experimental therapeutics 2000;293(3):1048-62.
1999: T Dubuffet; Adrian Newman-Tancredi; Didier Cussac; Valérie Audinot; A Loutz; Mark J Millan; Gilbert Lavielle
Novel benzopyrano[3,4-c]pyrrole derivatives as potent and selective dopamine D3 receptor antagonist.
Bioorganic & medicinal chemistry letters 1999;9(14):2059-64.
1998: Mark J Millan; rudy schreiber; Anne Dekeyne; Jean-Michel Rivet; K Bervoets; M Mavridis; Claude Sebban; S Maurel-Remy; Adrian Newman-Tancredi; Michael Spedding; O Muller; Gilbert Lavielle; Mauricette Brocco
S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: II. Functional profile in comparison to clozapine and haloperidol.
The Journal of pharmacology and experimental therapeutics 1998;286(3):1356-73.
1998: Mark J Millan; Alain Gobert; Adrian Newman-Tancredi; Valérie Audinot; Françoise Lejeune; Jean-Michel Rivet; Didier Cussac; Jean-Paul Nicolas; O Muller; Gilbert Lavielle
S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
The Journal of pharmacology and experimental therapeutics 1998;286(3):1341-55.
1998: Bernard Cimetière; T Dubuffet; C Landras; JJ Descombes; Serge Simonet; Tony J Verbeuren; Gilbert Lavielle
New tetrahydronaphthalene derivatives as combined thromboxane receptor antagonists and thromboxane synthase inhibitors.
Bioorganic & medicinal chemistry letters 1998;8(11):1381-6.
1998: Bernard Cimetière; T Dubuffet; O Muller; JJ Descombes; Serge Simonet; Michel Laubie; Tony J Verbeuren; Gilbert Lavielle
Synthesis and biological evaluation of new tetrahydronaphthalene derivatives as thromboxane receptor antagonists.
Bioorganic & medicinal chemistry letters 1998;8(11):1375-80.
1997: Tony J Verbeuren; Marie-Odile Vallez; Gilbert Lavielle; E Bouskela
Activation of thromboxane receptors and the induction of vasomotion in the hamster cheek pouch microcirculation.
British journal of pharmacology 1997;122(5):859-66.
1997: Adrian Newman-Tancredi; C Conte; C Chaput; Laurence Verrièle; V Audinot-Bouchez; S Lochon; Gilbert Lavielle; Mark J Millan
Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
Naunyn-Schmiedeberg's archives of pharmacology 1997;355(6):682-8.
1997: Valérie Audinot; S Lochon; Adrian Newman-Tancredi; Gilbert Lavielle; Mark J Millan
Binding profile of the novel 5-HT1B/1D receptor antagonist, [3H]GR 125,743, in guinea-pig brain: a comparison with [3H]5-carboxamidotryptamine.
European journal of pharmacology 1997;327(2-3):247-56.
1997: Mark J Millan; Jean-Louis Peglion; Gilbert Lavielle; S Perrin-Monneyron
5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists.
European journal of pharmacology 1997;325(1):9-12.
1997: Serge Simonet; JJ Descombes; Marie-Odile Vallez; T Dubuffet; Gilbert Lavielle; Tony J Verbeuren
S 18886, a new thromboxane (TP)-receptor antagonist is the active isomer of S 18204 in all species, except in the guinea-pig.
Advances in experimental medicine and biology 1997;433():173-6.
1991: Mark J Millan; H Canton; Jean-Michel Rivet; Françoise Lejeune; Michel Laubie; Gilbert Lavielle
S 14671: a novel naphthylpiperazine 5-HT1A agonist of high efficacy and exceptional in vivo potency.
European journal of pharmacology 1991;203(2):319-22.